Krybit has claimed three healthcare targets in a single day, listing an Indian cancer care platform, an Indian pharmaceutical research organization, and a Brazilian ophthalmology hospital on its leak site on August 26.
Karkinos Healthcare Private Limited, which operates karkinos.in, describes itself as a comprehensive cancer care platform and healthcare technology company. Jindal Life Science Private Limited, behind jindallifescience.com, is a full-service contract research organization serving pharmaceutical clients. The third victim, NEO Núcleo de Excelência em Oftalmologia, runs neooftalmo.com.br as an ophthalmology hospital in Brazil.
RansomLook timestamps show the three entries landing within the same minute on August 26 as part of a wider Krybit mass listing that also hit finance, retail, and industrial domains. Ransomware.live recorded all three healthcare victims the same day.
The claims are unconfirmed, and none of the three companies has issued a public statement. Krybit has steadily targeted healthcare in recent weeks, previously claiming Labindia, an Indian laboratory instruments maker, and Singapore clinic operator ProHealth in August.
For pharma, biotech, and oncology organizations, the same-day pattern highlights how fast threat groups cycle through sector targets. Companies should treat unverified claims as possible breaches, review network logs for the intrusion window, and confirm that cancer and clinical trial data is encrypted both at rest and in transit.
